お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:心房細動の世界市場:処置別および地域別市場分析、シェア、動向、規模、予測(2020年~2026年)
市場調査レポート
商品コード
941366

心房細動の世界市場:処置別および地域別市場分析、シェア、動向、規模、予測(2020年~2026年)

Atrial Fibrillation Market, By Procedure (Pharmacological Drugs, Non-Pharmacological Treatment ) and By Geography (EU, NA, APAC, LATAM, and MEA) - Analysis, Size, Share, Trends, & Forecast from 2020-2026

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 177 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.20円
心房細動の世界市場:処置別および地域別市場分析、シェア、動向、規模、予測(2020年~2026年)
出版日: 2020年05月01日
発行: AnalystView Market Insights
ページ情報: 英文 177 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の心房細動市場は、2019年までに143億8,000万米ドルと評価され、予測期間中の2020年から2026年の間にCAGR 14.9%で成長すると予測されています。

高齢者人口の増加に伴う心房細動の有病率の増加が、 世界の心房細動市場の成長を促進する主要な要因となっています。さらに、高血圧、僧帽弁狭窄症、肺塞栓症、甲状腺機能亢進症、肥満、肺炎などの疾患を引き起こす心房細動の発生率の増加は、この障害の有病率の増加の原因となる注目すべき要因の一つです。世界保健機関(WHO)によれば、世界中の75歳以上人口の約11%が心房細動に苦しんでいます。さらに、心臓の不整脈を治療するためのカテーテルアブレーション選好の増加と相まって、医療観光の増加が、業界成長をさらに促進します。逆に、心房細動に関する医薬品に対する否定的な印象、デバイスに関連する高コスト、および熟練した専門家の不足が、今後の市場の成長を阻害すると予想されています。それ以上に、低侵襲的処置と技術進歩に対するニーズの高まりにより、予測期間中に市場全体で有益な成長機会が生まれると予測されています。

当レポートでは、世界の心房細動市場について調査分析し、市場概要、市場動向、産業分析、市場情勢、セグメント別の市場分析、主要企業などについて、体系的な情報を提供しています。

目次

第1章 心房細動市場の市場概要

  • 調査範囲
  • 前提条件と調査手法

第2章 エグゼクティブサマリー

  • 市場区分
    • 処置別市場
    • 地域別市場
  • 競合考察

第3章 心房細動の主要な市場動向

  • 市場成長要因
    • 市場成長要因の影響分析
  • 市場阻害要因
    • 市場阻害要因の影響分析
  • 市場機会
  • 市場の将来動向

第4章 心房細動産業研究

  • ポーターのファイブフォース分析
  • マーケティング戦略分析
  • 成長見通しマッピング
  • 規制フレームワーク分析

第5章 心房細動市場情勢

  • 市場シェア分析
  • 主な革新者
  • 主要メーカー別の内訳データ
    • 既存企業分析
    • 新興企業分析

第6章 心房細動市場-処置別

  • 概要
    • セグメントシェア分析、処置別、2019&2026(%)
  • 薬理学的薬物
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)
  • 非薬理学的治療
    • 概要
    • 市場分析、予測、および前年比成長率、2015年-2026年(百万米ドル)

第7章 心房細動市場- 地域

  • イントロダクション
    • 地域別セグメントシェア分析、2019年および2026年(%)
  • 北米
    • 概要
    • 北米の主要メーカー
    • 北米の市場規模と予測、国別、2015年-2026年(百万米ドル)
    • 北米の市場規模と予測、処置別、2015年-2026年(百万米ドル)
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • 欧州の市場規模と予測、国別、2015年-2026年(百万米ドル)
    • 欧州の市場規模と予測、処置別、2015年-2026年(百万米ドル)
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • その他の欧州諸国
  • アジア太平洋(APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • アジア太平洋の市場規模と予測、国別、2015年-2026年(百万米ドル)
    • アジア太平洋市場のサイズと予測、処置別、2015年-2026年(百万米ドル)
    • インド
    • 中国
    • 日本
    • 韓国
    • その他のアジア太平洋諸国
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ラテンアメリカの市場規模と予測、国別、2015年-2026年(百万米ドル)
    • ラテンアメリカの市場規模と予測、処置別、2015年-2026年(百万米ドル)
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ諸国
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • 中東・アフリカの市場規模と予測、国別、2015年-2026年(百万米ドル)
    • 中東・アフリカの市場規模と予測、処置、2015~2026年(百万米ドル)
    • サウジアラビア
    • アラブ首長国連邦

第8章 ベンダーの分析

  • Sanofi-Aventis
    • 会社概要
    • 財務実績
    • 処置のベンチマーク
    • 戦略的取り組み
  • AtriCure Inc.
  • Biosense Webster Inc.
  • CardioFocus Inc.
  • Bristol-Myers Squibb Corporation
  • Boston Scientific Corporation
  • Endoscopic Technologies Inc.
  • Johnson&Johnson Ltd.
  • St. Jude Medical Inc.
  • Boehringer Ingelheim GmbH。

第9章 アナリストの全方位的見解

第10章 付録

  • 調査方法
  • 参考文献
  • 略語
  • 免責事項
  • お問い合わせ
図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Atrial Fibrillation market: ProcedureSnapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Procedure
  • TABLE Global Atrial Fibrillation market, by Procedure2015-2026 (USD Million)
  • TABLE Atrial Fibrillation market: Regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Atrial Fibrillation market, by Region 2015-2026 (USD Million)
  • TABLE North America Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
  • TABLE North America Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
  • TABLE Europe Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
  • TABLE Europe Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
  • TABLE Asia Pacific Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
  • TABLE Asia Pacific Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
  • TABLE Latin America Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
  • TABLE Latin America Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Atrial Fibrillation market, by Country, 2015-2026 (USD Million)
  • TABLE Middle East and Africa Atrial Fibrillation market, by Procedure, 2015-2026 (USD Million)

List of Figures

  • FIGURE Atrial Fibrillation market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Procedure segment market share analysis, 2019 & 2026
  • FIGURE Procedure segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Pharmacological Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Anti-coagulant Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Anti-arrhythmic Drugs market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Non-Pharmacological Treatment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Catheter Ablation Procedures market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Maze Surgery market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Electric Cardioversion Implants market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE HIFU market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Radiofrequency market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Laser market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Microwave market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Cryoablation market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Regional segment market share analysis, 2019 & 2026
  • FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE North America Atrial Fibrillation market share and leading players, 2018
  • FIGURE Europe Atrial Fibrillation market share and leading players, 2018
  • FIGURE Asia Pacific Atrial Fibrillation market share and leading players, 2018
  • FIGURE Latin America Atrial Fibrillation market share and leading players, 2018
  • FIGURE Middle East and Africa Atrial Fibrillation market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Canada Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Europe Atrial Fibrillation market share analysis by country, 2018
  • FIGURE Germany Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Spain Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Italy Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE UK Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE France Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of the Europe Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Asia Pacific Atrial Fibrillation market share analysis by country, 2018
  • FIGURE India Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE China Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Japan Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE South Korea Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Singapore Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of APAC Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Latin America Atrial Fibrillation market share analysis by country, 2018
  • FIGURE Brazil Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Mexico Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Argentina Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Rest of LATAM Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE Middle East and Africa Atrial Fibrillation market share analysis by country, 2018
  • FIGURE Saudi Arabia Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
  • FIGURE United Arab Emirates Atrial Fibrillation market size, forecast and trend analysis, 2015 to 2026 (USD Million)
目次

REPORT HIGHLIGHT

Atrial fibrillation market was valued at USD 14.38 billion by 2019, growing with 14.9% CAGR during the forecast period, 2020-2026.

Atrial fibrillation is an irregular or rapid rhythm of the heart, which increases the risk of stroke, heart, blood clots, and other complications. In atrial fibrillation, the upper chambers of the heartbeats irregularly in a very rapid pattern, which results in slowing down of blood flow. The complications of atrial fibrillation include pressure, angina, or chest pain that leads to congestive heart failure. Fainting, fatigue, dizziness, and confusion are some of the symptoms of atrial fibrillation.

Market Dynamics

The growing prevalence of atrial fibrillation along with the increasing geriatric population is a major factor driving the growth of the global atrial fibrillation market. In addition, the growing incidence rates of atrial fibrillation causing diseases such as high blood pressure, mitral stenosis, pulmonary embolus, hyperthyroidism, obesity, and pneumonia is one of the notable factors responsible for the growing prevalence of this disorder. According to the World Health Organization (WHO), about 11% of the population aged 75 years and above all across the globe, suffer from atrial fibrillation. Furthermore, the rise in medical tourism coupled with the rising preference of catheter ablation for treating cardiac arrhythmia will propel the industry growth further. Conversely, the unfavorable inclination towards pharmaceutical drugs over atrial fibrillation, high costs associated with the devices, and lack of skilled professionals are expected to hamper the market growth in the coming future. On the contrary, the rising need for minimally invasive procedures and technological advancements are predicted to create lucrative growth opportunities in the overall market during the forecast period.

Procedure Takeaway

Based on the procedure, the worldwide market for atrial fibrillation is categorized into pharmacological drugs and non-pharmacological treatments. The pharmacological drugs segment includes anticoagulation and antiarrhythmic drugs. Further, the non-pharmacological treatment segment is sub-categorized into electric cardioversion, maze surgery, and the catheter ablation procedures into HIFU, radiofrequency, laser, microwave, and cryoablation. Among these, the catheter ablation surgical devices are the most commonly used for treating cardiac arrhythmias. These surgical devices are also used for the treatment of atrial fibrillation when anti-coagulant drugs and other medications are not tolerated or administered by the patient. Thus, the catheter ablation segment is estimated to dominate the market in terms of revenue in the forecast period. Moreover, an increase in the adoption rate of the catheter ablation system is expected to increase steadily, owing to the growing procedural success rate in patients that suffer from permanent, persistent, and paroxysmal conditions of atrial fibrillation.

Among the surgical catheter ablation, microwave and radiofrequency are the most commonly used catheter ablation procedures. The faster recovery rate of these procedures and the decreased size of the cardiac incision are other factors contributing to the segmental market growth.

REGIONAL TAKEAWAY

Regionally, the global industry is divided into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The North America region accounted for the majority of share in 2019 and is estimated to dominate the industry during the forecast period. This dominance is majorly attributed to the growing adoption of technological advancements and the presence of sophisticated healthcare infrastructure. In addition, the governments of several countries and market players are investing more in atrial fibrillation procedures, which is anticipated to boost the regional market growth.

On the other hand, the Asia Pacific market for atrial fibrillation is anticipated to witness the fastest growth during the forecast period. This is mainly owing to the vast population and various age groups being vulnerable to cardiac diseases. Besides, the rising demand for atrial fibrillation devices and improving healthcare infrastructure are predicted to propel the growth of the Asia Pacific region.

COVID-19 Impact

The sudden outbreak of the COVID-19 pandemic has immensely affected the global atrial fibrillation market. The key players of the industry have built and broken various value-grab opportunities to sustain in these trying times. They are capitalizing on novel strategies to obtain and maintain a stable revenue income. However, the global market is estimated to recover soon after the coronavirus chaos.

KEY VENDOR TAKEAWAY

The leading players of the global atrial fibrillation market include Sanofi-Aventis, AtriCure Inc., Biosense Webster Inc., CardioFocus Inc., Bristol-Myers Squibb Corporation, Boston Scientific Corporation, Endoscopic Technologies Inc., Johnson & Johnson Ltd., St. Jude Medical Inc., and Boehringer Ingelheim GmbH. These players are implementing various strategies such as mergers, acquisitions, and technological advancements to hold a strong position in the global industry.

For instance, in August 2019, a leading innovator in treatments for left atrial appendage (LAA) and atrial fibrillation, AtriCure, Inc. acquired SentreHEART by entering into an agreement. The company's aim behind this acquisition is to provide better atrial fibrillation treatment and expand their business.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

Scope of the Report

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

Sanofi-Aventis

AtriCure Inc.

Biosense Webster Inc.

CardioFocus Inc.

Bristol-Myers Squibb Corporation

Boston Scientific Corporation

Endoscopic Technologies Inc.

Johnson & Johnson Ltd.

Jude Medical Inc.

Boehringer Ingelheim GmbH

ATRIAL FIBRILLATION MARKET, BY PROCEDURE

Pharmacological Drugs

Anti-arrhythmic Drugs

Anticoagulant Drugs

Non-Pharmacological Treatment

Catheter Ablation Procedures

HIFU

Radiofrequency

Laser

Microwave

Cryoablation

Maze Surgery

Electric Cardioversion

ATRIAL FIBRILLATION MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

The Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. ATRIAL FIBRILLATION MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Procedure
    • 2.1.2. Market Snippet by Region
  • 2.2. Competitive Insights

3. ATRIAL FIBRILLATION KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. ATRIAL FIBRILLATION INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ATRIAL FIBRILLATION MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. ATRIAL FIBRILLATION MARKET - BY PROCEDURE

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Procedure, 2019 & 2026 (%)
  • 6.2. Pharmacological Drugs
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.1. Anti-coagulant Drugs
      • 6.2.2.1.1. Overview
      • 6.2.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.2.2.2. Anti-arrhythmic Drugs
      • 6.2.2.2.1. Overview
      • 6.2.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 6.3. Non-Pharmacological Treatment
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1. Catheter Ablation Procedures
      • 6.3.2.1.1. Overview
      • 6.3.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1.2.1. HIFU
      • 6.3.2.1.2.1.1. Overview
      • 6.3.2.1.2.1.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1.2.2. Radiofrequency
      • 6.3.2.1.2.2.1. Overview
      • 6.3.2.1.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1.2.3. Laser
      • 6.3.2.1.2.3.1. Overview
      • 6.3.2.1.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1.2.4. Microwave
      • 6.3.2.1.2.4.1. Overview
      • 6.3.2.1.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.1.2.3.5. Cryoablation
      • 6.3.2.1.2.4.3. Overview
      • 6.3.2.1.2.4.4. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.2. Maze Surgery
      • 6.3.2.2.1. Overview
      • 6.3.2.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
      • 6.3.2.3. Electric Cardioversion
      • 6.3.2.3.1. Overview
      • 6.3.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. ATRIAL FIBRILLATION MARKET- BY GEOGRAPHY

  • 7.1. Introduction
    • 7.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
  • 7.2. North America
    • 7.2.1. Overview
    • 7.2.2. Key Manufacturers in North America
    • 7.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 7.2.4. North America Market Size and Forecast, By Procedure, 2015 - 2026 (US$ Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Overview
      • 7.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.2.6. Canada
      • 7.2.6.1. Overview
      • 7.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.3. Europe
    • 7.3.1. Overview
    • 7.3.2. Key Manufacturers in Europe
    • 7.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 7.3.4. Europe Market Size and Forecast, By Procedure, 2015 - 2026 (US$ Million)
    • 7.3.5. Germany
      • 7.3.5.1. Overview
      • 7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.3.6. Italy
      • 7.3.6.1. Overview
      • 7.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.3.7. United Kingdom
      • 7.3.7.1. Overview
      • 7.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.3.8. France
      • 7.3.8.1. Overview
      • 7.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.3.9. Rest of Europe
      • 7.3.9.1. Overview
      • 7.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.4. Asia Pacific (APAC)
    • 7.4.1. Overview
    • 7.4.2. Key Manufacturers in Asia Pacific
    • 7.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 7.4.4. Asia Pacific Market Size and Forecast, By Procedure, 2015 - 2026 (US$ Million)
    • 7.4.5. India
      • 7.4.5.1. Overview
      • 7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.4.6. China
      • 7.4.6.1. Overview
      • 7.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.4.7. Japan
      • 7.4.7.1. Overview
      • 7.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Overview
      • 7.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.4.9. Rest of APAC
      • 7.4.9.1. Overview
      • 7.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.5. Latin America
    • 7.5.1. Overview
    • 7.5.2. Key Manufacturers in Latin America
    • 7.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 7.5.4. Latin America Market Size and Forecast, By Procedure, 2015 - 2026 (US$ Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Overview
      • 7.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Overview
      • 7.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Overview
      • 7.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.5.8. Rest of LATAM
      • 7.5.8.1. Overview
      • 7.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Overview
    • 7.6.2. Key Manufacturers in Middle East and Africa
    • 7.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
    • 7.6.4. Middle East and Africa Market Size and Forecast, By Procedure, 2015 - 2026 (US$ Million)
    • 7.6.5. Saudi Arabia
      • 7.6.5.1. Overview
      • 7.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
    • 7.6.6. United Arab Emirates
      • 7.6.6.1. Overview
      • 7.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. KEY VENDOR ANALYSIS

  • 8.1. Sanofi-Aventis
    • 8.1.1. Company Snapshot
    • 8.1.2. Financial Performance
    • 8.1.3. Procedure Benchmarking
    • 8.1.4. Strategic Initiatives
  • 8.2. AtriCure Inc.
  • 8.3. Biosense Webster Inc.
  • 8.4. CardioFocus Inc.
  • 8.5. Bristol-Myers Squibb Corporation
  • 8.6. Boston Scientific Corporation
  • 8.7. Endoscopic Technologies Inc.
  • 8.8. Johnson & Johnson Ltd.
  • 8.9. St. Jude Medical Inc.
  • 8.10. Boehringer Ingelheim GmbH.

9. 360 DEGREE ANALYSTVIEW

10. APPENDIX

  • 10.1. Research Methodology
  • 10.2. References
  • 10.3. Abbreviations
  • 10.4. Disclaimer
  • 10.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.